<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Heleen Masset</style></author><author><style face="normal" font="default" size="100%">Amber Van Laer</style></author><author><style face="normal" font="default" size="100%">Members of the HERA-BE-WGS initiative</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">be.Prepared: Transition to timely genomic resistance surveillance</style></title><secondary-title><style face="normal" font="default" size="100%">AMR Conference of the Belgian Presidency, One World One Health</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">AMR</style></keyword><keyword><style  face="normal" font="default" size="100%">Infectious diseases</style></keyword><keyword><style  face="normal" font="default" size="100%">Surveillance</style></keyword><keyword><style  face="normal" font="default" size="100%">Whole genome sequencing (WGS)</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">07/05/2024</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">AMR Conference of the Belgian Presidency, One World One Health</style></publisher><pub-location><style face="normal" font="default" size="100%">Brussels, Belgium</style></pub-location><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;In recent years, there has been a major global push to improve whole genome sequencing (WGS) infrastructure in response to the COVID-19 pandemic. SARS-CoV-2 WGS has proven to be highly valuable for public health, helping to identify mutations, track new variants, and support vaccine development. Building on this experience, there is now a clear need for a flexible system that can be used to monitor a wide range of pathogens when needed for public health. A key step in improving infectious disease surveillance is connecting and combining different types of data—such as genomic, clinical, and epidemiological information—to get a more complete picture and respond more effectively to future health threats.&lt;/p&gt;
</style></abstract></record></records></xml>